Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

This study describes the effects of bezafibrate, an analogue of clofibrate, on the plasma lipid and lipoprotein profiles of 11 hypertriglyceridemic subjects and on their metabolism of apolipoproteins A-I, A-II, and B. The major action of the drug was to lower plasma triglyceride (by 58%; P less than...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Shepherd, J, Packard, C J, Stewart, J M, Atmeh, R F, Clark, R S, Boag, D E, Carr, K, Lorimer, A R, Ballantyne, D, Morgan, H G
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 1984
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425409/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6511921/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111643
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!